Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;329:966-968 (23 October), doi:10.1136/bmj.329.7472.966
Stephen Senn, professor of statistics1
1 Department of Statistics, University of Glasgow, Glasgow G12 8QQ stephen@stats.gla.ac.uk
Most drug trials assume that patients respond consistently to treatment, but the assumption is rarely tested. If patients vary randomly in their response to a drug rather than some patients never responding, searches for a genetic basis for non-response are futile
| The first 150 words of the full text of this article appear below. |
One common interpretation is that the treatment works for 70% of patients 100% of the time and for 30% of the patients 0% of the time. However, nothing in the data forbids a radically different interpretationnamely, that the treatment works in 100% of the patients 70% of the time. In the first case, ability to succeed on treatment is a permanent feature of the patient. In the second case, individual response cannot be predicted: the patients are indistinguishable from each other regarding response to treatment. They sometimes respond and they sometimes do not. Intermediate cases between these two extremes are,
Read all Rapid Responses